Exam (elaborations)
Advanced Pharmacology NSG 533 2024/2025 verified Solution
- Course
- Institution
Advanced Pharmacology NSG 533 2024/2025 verified Solution
[Show more]
Content preview
Passed!!2024/2025
Advanced Pharmacology NSG 533
EP is a 38-year-old female patient that comes in for diabetes education and
management. She was diagnosed 12 years ago and states lately she is not able to
control her diet although she continues a 1600 calorie diet with appropriate daily
carbohydrate intake (per dietitian prescription) and walks 40 minutes every day of
the week. She states compliance with all medications. She denies any history of
hypoglycemia despite being able to identify signs and symptoms and describe
appropriate treatment strategies.
PMH: T2DM, HTN, obesity, depression, s/p thyroidectomy due to thyroid cancer
FmHx: Noncontributory
SHx: (−) Smoking, alcohol use, past marijuana use while in high school
Medications: Metformin 850 mg tid, glipizide 20 mg bid, lisinopril 20 mg daily,
sertraline 100 mg daily, multivitamin daily
Vitals: BP 128/82 mg Hg; P 72 beats/min; BMI 31 m/kg2
Laboratory test results: Na 134 mEq/L, K 5.4 mEq/L, Cl 106 mEq/L, BUN Answer:
Exenatide - Exenatide (Bydureon) once weekly has been able to demonstrate
weight loss and decrease A1C% by 0.7% to 1.2% in clinical trials; however it is
contraindicated for EP due to the self-reported history of thyroid cancer.
Dapagliflozin - Dapagliflozin (Farxiga) is contraindicated in this patient due to
hyperkalemia which could be made worse by this drug. The package insert does
not indicate a specific potassium concentration cut off to no longer use this
medication; however, there are better choices in this patient.
Sitagliptin - Sitagliptin (Januvia) is able to obtain an A1C goal of less than 7% based
on clinical trials and currently the patient does not have any cautionary objective
measures to not use this medication. DPP-IV inhibitors are weight neutral. DPP-IV
inhibitors can be used in patients taking sulfonylureas; however, it may be
recommended to reduce or stop the sulfonylurea dose.
Acarbose - Acarbose (Precose) is not recommended for initial management and is
associated with significant GI side effects. More information would be needed
, Passed!!
2024/2025
regarding fasting and post-prandial numbers. In addition, adding acarbose would
only lower A1c by 0.8% at best and therefore would not achieve the desired A1C
goal of <7%
JR is a 68-year-old African American man with a new diagnosis of T2DM. He was
classified as having prediabetes (at risk for developing diabetes) 5 years before
the diagnosis and has a strong family history of type 2 diabetes. JR's blood
pressure was 150/92 mm Hg. His laboratory results revealed an A1C of 8.1%,
normal cholesterol panel, and normal renal/hepatic function were noted with
today's laboratory test results.
Past medical history: Hypertension (diagnosed 4 y ago) Hyperlipidemia (diagnosed
2 y ago) Pancreatitis (idiopathic) (acute hospitalization 3 y ago)
Family history: Type 2 diabetes
Medication: HCTZ 25 mg daily, simvastatin 10 mg daily
Allergies: SMZ/TMP
Vitals: BP: 150/92 mm Hg P: 78 beats/min RR: 12 rpm Waist Circumference: 46 in
Weight: 267 lb Height: 5 ′ 6 ″ BMI: 43.1 kg/m 2
Despite improvements in the past six weeks due to lifestyle changes and exercise,
drug therapy is to be started for JR's diabet Answer: Metformin is the drug of
choice recommended for most patients with diabetes in addition to lifestyle
modifications assuming no contraindications or intolerabilities are present upon
evaluation. Metformin has also shown to provide positive weight neutral/loss
effects in obese patients. It is crucial to know the renal status of patients
commencing metformin therapy to limit the risk of lactic acidosis (JR is without
contraindication).
Since his entry A1C is >7.5%, dual therapy is indicated. There are several potential
choices. The second step can be a dipeptidyl peptidase-4 inhibitor, it can be a
glucagon-like peptide-1 (GLP-1) receptor agonist, it can be a TZD, it can be a
, Passed!!
2024/2025
sulfonylurea agent, it can be a SGLT2 inhibitor, or it could be basal insulin.
Anything next can be tried depending on what suits the circumstance
DPP4 inhibitors are weight neutral bet relatively benign side effect profile.
Sitagliptin has been associated with case reports of pancreatitis, so this specific
agent should be avoided. $$$
GLP-1 analog and has data to support an A1C reduction necessary to gain
glycemic control and may assist with weight loss goals for this patient. New
information suggests these agents may provide benefits in those with ASCVD. JR
has a past history of pancreatitis and GLP-1 analogs are not recommended due to
this contraindication
TZDs have data to support an A1C reduction necessary to gain glycemic control,
but are associated with weight gain, negative effects on lipids and increased risk
of fracture. Until recently, TZDs have also been linked to increased CV events and
use has fallen out of favor
Sulfonylureas provide excellent A1C lowering, but are also associated with weight
gain. They also have the potential to cause hypoglycemia, so patient education is
crucial. Because of his allergies to "sulfa", use would be contr
A patient with type 1 diabetes reports taking propranolol for hypertension. What
concern does this information present for the provider? Answer: A patient
with Type 1 DM is insulin dependent for glucose control and at high risk for
hypoglycemic episodes. Propanolol causes prolonged hypoglycemic episodes.
Needs to switch to ACE or ARB.
A provider teaches a patient who has been diagnosed with hypothyroidism about
a new prescription for levothyroxine. Which statement by the patient indicates a
need for further teaching?
a. "I should not take heartburn medication without consulting my provider first."
b. "I should report insomnia, tremors, and an increased heart rate to my
provider."
, Passed!!
2024/2025
c. "If I take a multivitamin with iron, I should take it 4 hours after the
levothyroxine."
d. "If I take calcium supplements, I may need to decrease my dose of
levothyroxine." Answer: D. Calcium may reduce levothyroxine absorption.
Further education is needed if the patient feels she can take half of a prescribed
medication.
MC has undiagnosed multiple gastric ulcers. Shortly after consuming a large meal
and alcohol he experiences significant GI distress. He takes an OTC heartburn
remedy. Within a minute or two he develops what he will later describe as
"belching, nausea and a bad bloated feeling". Several of the ulcers began to bleed
and he becomes profoundly hypotensive from the blood loss and is taken to the
ED. Endoscopy confirms multiple bleeds; the endoscopist remarks that it appears
as if the lesions had been literally stretched apart causing additional tissue
damage. What did the patient most likely take (i.e. what was the OTC remedy)?
Answer: I would accept Alka-Selzer. I contains NaHCO3 (as well as ASA). In the
presence of HCL it Liberates CO2, that can cause gastric distention, belching and
nausea. The reaction is fairly swift allowing little time for dissipation. Tums, its
primary ingredient calcium carbonate which when taken cause a reaction with the
stomach acid such as production of carbon dioxide gas which can cause bloating
and the stomach to stretch to tear the ulcers open.
On your way to this examination, you experience the vulnerable feeling that an
attack of acute diarrhea is imminent! If you stop at a drug store, which anti-
diarrheal drugs could you buy without a prescription even though it is chemically
related to the strong opioid analgesic meperidine (but acts only on the peripheral
opioid receptor)? Answer: Loperamide
JA has multiple medical problems and is taking several drugs including
theophylline, warfarin and phenytoin. His conditions were well controlled, but
recently he started to experience some GI distress for which of his "well
intentioned friends" gave him some medication. He presents to you with toxic
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller Schoolflix. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $16.49. You're not tied to anything after your purchase.
Can Stuvia be trusted?
4.6 stars on Google & Trustpilot (+1000 reviews)
75323 documents were sold in the last 30 days
Founded in 2010, the go-to place to buy study notes for 14 years now